Young people in the United Kingdom will be offered the meningitis B vaccine starting July 31 as part of an expanded public health initiative. The Joint Committee on Vaccination and Immunisation (JCVI) has recommended offering the two-dose vaccine to all Year 14 pupils and individuals under 25 who are beginning university in September.
This decision marks a shift in advice, following a previous assessment that indicated no immediate need for a broader rollout after a surge in private vaccine demand during an outbreak in Kent. The JCVI's revised recommendation acknowledges that teenagers are at a higher risk of contracting and becoming severely ill from meningitis B. Proximity and close contact within university settings, including shared living spaces and social gatherings, are cited as key factors contributing to this increased risk among students.
The Department of Health has stated that officials are reviewing the recommendations to determine if the vaccination program can be implemented in Northern Ireland. A policy decision will be made by the minister in due course.
Previously, the government had not seen a need for a widespread campaign, but the JCVI's updated advice reflects a greater understanding of the vulnerabilities of this age group. The move aims to provide a proactive measure against the potentially life-threatening bacterial infection.